Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ETIMS: Peptide-coupled PBMC in RRMS
NCT01414634Phase 2Completed
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Feb 2010
- Primary completion
- Oct 2012
- Modality
- Cell Therapies
01
Overview
A Phase 2 trial of autologous myelin peptide-coupled cells in relapsing-remitting multiple sclerosis (RRMS), secondary-progressive multiple sclerosis (SPMS), sponsored by University Medical Center Hamburg-Eppendorf. Started Feb 2010; status: completed.
02
Drugs
autologous myelin peptide-coupled cells
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)secondary-progressive multiple sclerosis (SPMS)
Beyond the preview
Go deeper on NCT01414634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01414634.